Mark Bratt

Mark Bratt is an experienced professional in process development and engineering, currently serving as Associate Director and Head of Drug Substance Development at Jazz Pharmaceuticals since March 2022. Previously, Mark held several positions at GW Pharmaceuticals, including Senior Manager of Process Development Engineering, where responsibilities involved technical transfers and transformational projects. Mark has also worked at IntensiChem Ltd as Director of Chemistry, focusing on process development, business development, and R&D. Additional experience includes roles at Pfizer and GSK, emphasizing process improvement and manufacturing support, along with a history of contributions to the Specialty Chemicals Sector RSC. Mark holds a PhD in Chemistry with a focus on synthetic methodology from the University of Warwick.